Whether the upregulation of NDPK-B and SK4 is the phenotypic characteristic\in ARVC-patients, which is the most important question for this study, cannot be addressed, although it may be the case, at least in some ARVC-patients with a certain gene mutation. The gene discussed is NME2; the disease is arrhythmogenic right ventricular cardiomyopathy.